{
    "2021-04-27": [
        [
            {
                "time": "",
                "original_text": "沃森生物一季度净利润同比增277.5% 自主疫苗产品销量实现大幅增长",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利润",
                        "同比增长",
                        "疫苗",
                        "销量增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "“海啸式”疫情冲击印度，多家医药公司回应，五大券商把脉后市",
                "features": {
                    "keywords": [
                        "疫情",
                        "印度",
                        "医药公司",
                        "券商",
                        "后市"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：一季度同比扭亏 盈利3215.88万元",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "扭亏为盈",
                        "盈利"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)与圣诺生物等拟就“针对通用流感病毒的siRNA药物”开发项目开展合作",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "圣诺生物",
                        "siRNA药物",
                        "合作开发"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "研发合作"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)一季度扭亏为盈 归母净利为3215.88万元",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "扭亏为盈",
                        "归母净利"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：2021年一季度净利同比增长277.5%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利",
                        "同比增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)：签署针对通用流感病毒的siRNA药物的抗病毒核酸干扰药物合作开发和许可协议",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "siRNA药物",
                        "合作开发",
                        "许可协议"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "研发合作"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)一季度扣非净利润7502.39万元 同比扭亏为盈",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "扣非净利润",
                        "扭亏为盈"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：签署13价肺炎球菌多糖结合疫苗海外销售协议",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "13价肺炎球菌疫苗",
                        "海外销售协议"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "国际市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "云南区域股市周报：6576万融资买入贝泰妮 恩捷股份成云南股市值亚军",
                "features": {
                    "keywords": [
                        "云南",
                        "股市周报",
                        "贝泰妮",
                        "恩捷股份",
                        "市值"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "区域经济",
                        "资本市场"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "专题研究 | 疫苗行业：2020年重磅品种持续放量，疫苗主要生产企业业绩大幅上升，疫苗行业信用中枢上移",
                "features": {
                    "keywords": [
                        "疫苗行业",
                        "重磅品种",
                        "业绩上升",
                        "信用中枢"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "行业分析"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A股融资融券日报：两融余额增加17.69亿元（4月26日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "增加"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "资本市场"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}